Superworth

Gossamer Bio shares outstanding GOSS

Diluted shares outstanding, averaged over each quarter, from 2018.

Latest quarter, to Jun 30, 2026
4.1M
On a year earlier
+44.7%
more shares

Gossamer Bio had 4.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is 44.7% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20252.9M+2%
FY20242.8M+1%
FY20232.8M+139%
FY20221.2M+25%
FY2021944.8K+3%
FY2020915.2K+19%
FY2019766K+706%
FY201895.1Kn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY264.1M+45%
Q1 FY262.9M+3%
Q4 FY252.9M+2%
Q3 FY252.8M+1%
Q2 FY252.8M−5%
Q1 FY252.8M+0%
Q4 FY242.8M+1%
Q3 FY242.8M+17%
Q2 FY243M+150%
Q1 FY242.8M+138%
Q4 FY232.8M+139%
Q3 FY232.4M+112%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Gossamer Bio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.